Target (CBDY) Common Equity (2013 - 2026)
Target (CBDY) reported Common Equity of -$8.5 million for Q1 2026, down 29.09% year-over-year from -$12.0 million in Q1 2025, and down 5.96% quarter-over-quarter from -$8.1 million in Q4 2025.
Target (CBDY) Common Equity (2013 - 2026) Analysis & Trends
Target (CBDY) has 14 years of Common Equity data on file, last reported at -$8.5 million in Q1 2026.
- Common Equity for Q1 2026 came in at -$8.5 million, down 29.09% year-over-year; the trailing twelve-month figure through Mar 2026 was -$8.5 million (down 29.09% YoY), and the FY2025 annual result was -$8.1 million, down 23.9% from the prior year.
- Common Equity eased to -$8.5 million in Q1 2026 per CBDY's latest filing, from -$8.1 million in the prior quarter.
- Over five years, Common Equity peaked at -$2.5 million in Q2 2022 and troughed at -$8.5 million in Q1 2026.
- A 5-year average of -$6.3 million and a median of -$6.9 million in 2023 frame the typical range for Common Equity.
- On a YoY basis, Common Equity climbed as much as 48.71% in 2022 and fell as far as 204.81% in 2022.
- A 5-year view of Common Equity shows it stood at -$6.6 million in 2022, then retreated by 6.29% to -$7.0 million in 2023, then increased by 6.67% to -$6.5 million in 2024, then decreased by 23.9% to -$8.1 million in 2025, then decreased by 5.96% to -$8.5 million in 2026.
- Business Quant data shows CBDY's Common Equity at -$8.5 million in Q1 2026, -$8.1 million in Q4 2025, and -$7.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.23 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 3.23 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 5.90 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 407.18 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 3.41 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.50 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.75 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 446.17 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.21 Bn |
| 10 | Target | - | - | 191,787.00 | -8.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.54 Mn |
| Dec 31, 2025 | -8.06 Mn |
| Sep 30, 2025 | -7.43 Mn |
| Jun 30, 2025 | -7.03 Mn |
| Mar 31, 2025 | -6.62 Mn |
| Dec 31, 2024 | -6.51 Mn |
| Sep 30, 2024 | -7.00 Mn |
| Jun 30, 2024 | -6.40 Mn |
| Mar 31, 2024 | -7.07 Mn |
| Dec 31, 2023 | -6.97 Mn |
| Sep 30, 2023 | -6.86 Mn |
| Jun 30, 2023 | -6.57 Mn |
| Mar 31, 2023 | -7.31 Mn |
| Dec 31, 2022 | -6.56 Mn |
| Sep 30, 2022 | -2.78 Mn |
| Jun 30, 2022 | -2.48 Mn |
| Mar 31, 2022 | -2.70 Mn |
| Dec 31, 2021 | -2.15 Mn |
| Sep 30, 2021 | -2.10 Mn |
| Jun 30, 2021 | -4.24 Mn |